when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

924 stories

May 11, 26Dr Silbermann on Clinical Trial Design Considerations in Multiple Myelomaonclive

May 11, 26MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive

May 11, 26GSK cuts deal with Sino to broaden reach of hepatitis B drugbiopharma dive

May 11, 26Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise pushendpoints

May 11, 26New home for Novo's Parkinson's cell therapy; GSK's deal to sell drug in Chinaendpoints

May 11, 26Inhibrx says combo therapy shrank more tumors than Merck's Keytruda aloneendpoints

May 11, 26Treatment Intensification Gains Momentum in mCSPC Managementonclive

May 11, 26STAT+: Astellas treatment offers new hope to a devastated rare disease communitystat

May 11, 26Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trialbiopharma dive

May 11, 26Biotech layoffs are easing, but is the worst over?biopharma dive

May 11, 26Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTonclive

May 11, 26Renal Cell Carcinoma: Real-World Factors in First-Line Treatment Selectiononclive

May 11, 26Expanding ctDNA Applications to RCC and Germ Cell Tumorsonclive

May 11, 26RAPNO Criteria and MRI Assessment in PLGG: Recommendations vs. Real-World Practiceonclive

May 11, 26ctDNA in Metastatic Urothelial Carcinomaonclive

May 11, 26Institutional Perspectives on Treatment Thresholds in PLGGonclive

May 11, 26Renal Cell Carcinoma: Practical Treatment Selection Across Risk Groupsonclive

May 11, 26STAT+: Five years after disaster, a rare disease community gets new chance at treatmentstat

May 11, 26STAT+: Medicare is spending far less than expected on new Alzheimer’s drugsstat

May 10, 26Nivolumab Plus SOC Therapy Shows Encouraging Disease Control in Grade Group 5 Prostate Canceronclive

May 10, 26Five Under 5: Top Oncology Videos for the Week of 5/3onclive

May 9, 26ADCs Reshape the Future of Lung Cancer Care: From Second-Line Therapy to Earlier Interventiononclive

May 9, 26The OncFive: Top Oncology Articles for the Week of 5/3onclive

May 8, 26Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCTonclive

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Dr Sznol on the Nuances of Recommending Neoadjuvant Therapy in Metastatic Melanomaonclive

May 8, 26Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhDonclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26Trump reportedly plans to fire FDA Commissioner Makarystat

May 8, 26FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinomaonclive

← prevpage 26 of 31next →